ZEG.DE vs. ABBV
Compare and contrast key facts about AstraZeneca PLC (ZEG.DE) and AbbVie Inc. (ABBV).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ZEG.DE or ABBV.
Correlation
The correlation between ZEG.DE and ABBV is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ZEG.DE vs. ABBV - Performance Comparison
Key characteristics
ZEG.DE:
0.89
ABBV:
0.70
ZEG.DE:
1.35
ABBV:
1.03
ZEG.DE:
1.19
ABBV:
1.16
ZEG.DE:
0.75
ABBV:
0.91
ZEG.DE:
1.74
ABBV:
2.11
ZEG.DE:
10.91%
ABBV:
8.21%
ZEG.DE:
21.27%
ABBV:
24.76%
ZEG.DE:
-55.49%
ABBV:
-45.09%
ZEG.DE:
-11.05%
ABBV:
-0.54%
Fundamentals
ZEG.DE:
€219.96B
ABBV:
$348.39B
ZEG.DE:
€4.29
ABBV:
$2.39
ZEG.DE:
33.08
ABBV:
82.57
ZEG.DE:
0.87
ABBV:
2.63
ZEG.DE:
€54.07B
ABBV:
$56.33B
ZEG.DE:
€43.87B
ABBV:
$41.47B
ZEG.DE:
€17.22B
ABBV:
$18.15B
Returns By Period
In the year-to-date period, ZEG.DE achieves a 10.51% return, which is significantly lower than ABBV's 14.11% return. Over the past 10 years, ZEG.DE has underperformed ABBV with an annualized return of 11.68%, while ABBV has yielded a comparatively higher 17.57% annualized return.
ZEG.DE
10.51%
8.38%
-8.62%
20.03%
11.00%
11.68%
ABBV
14.11%
16.38%
4.09%
18.88%
21.23%
17.57%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ZEG.DE vs. ABBV — Risk-Adjusted Performance Rank
ZEG.DE
ABBV
ZEG.DE vs. ABBV - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AstraZeneca PLC (ZEG.DE) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ZEG.DE vs. ABBV - Dividend Comparison
ZEG.DE's dividend yield for the trailing twelve months is around 2.35%, less than ABBV's 3.13% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ZEG.DE AstraZeneca PLC | 2.35% | 2.59% | 2.64% | 2.51% | 2.73% | 3.62% | 3.31% | 4.19% | 6.20% | 7.97% | 7.38% | 7.09% |
ABBV AbbVie Inc. | 3.13% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
Drawdowns
ZEG.DE vs. ABBV - Drawdown Comparison
The maximum ZEG.DE drawdown since its inception was -55.49%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for ZEG.DE and ABBV. For additional features, visit the drawdowns tool.
Volatility
ZEG.DE vs. ABBV - Volatility Comparison
AstraZeneca PLC (ZEG.DE) has a higher volatility of 7.32% compared to AbbVie Inc. (ABBV) at 6.90%. This indicates that ZEG.DE's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ZEG.DE vs. ABBV - Financials Comparison
This section allows you to compare key financial metrics between AstraZeneca PLC and AbbVie Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities